Baird analyst RJ Milligan said the weakness in Store Capital (STOR) from the weaker than expected results from Stericycle (SRCL) has presented a buying opportunity. The analyst said the shares have already under-performed year-to-date and now investors are incorrectly putting Store in the same bucket as Stericycle, though they are two different companies. He said Store has better tenant diversification, greater exposure to service-focused tenants, and more importantly has zero legacy issues. Milligan reiterated his Outperform rating on Store Capital shares, though he lowered his price target to $26 from $30.